Muhl Lars, Hersemeyer Karin, Preissner Klaus T, Weimer Thomas, Kanse Sandip M
Institute for Biochemistry, Medical School, Justus-Liebig-University Giessen, Giessen, Germany.
FEBS Lett. 2009 Jun 18;583(12):1994-8. doi: 10.1016/j.febslet.2009.05.012. Epub 2009 May 14.
Factor VII activating protease (FSAP) is associated with cardiovascular diseases and liver fibrosis. To understand the regulation of its proteolytic activity we have characterized recombinant FSAP-mutants over-expressed in HEK-293 cells. The secreted FSAP-protein concentration correlated inversely with the enzymatic activity of the FSAP-mutants. Over-expression of enzymatically active FSAP decreased cell viability, whereas inactive variants were expressed and secreted in adequate amounts. The naturally occurring G534E-variant exhibited reduced proteolytic activity. The DeltaEGF-3 mutant showed diminished binding to and activation by heparin. Hence, regulation of FSAP activity is dependent on its EGF-3 domain and over-expression of active variants induces cell death.
凝血因子 VII 激活蛋白酶(FSAP)与心血管疾病和肝纤维化相关。为了解其蛋白水解活性的调控机制,我们对在 HEK-293 细胞中过表达的重组 FSAP 突变体进行了表征。分泌的 FSAP 蛋白浓度与 FSAP 突变体的酶活性呈负相关。具有酶活性的 FSAP 的过表达降低了细胞活力,而无活性变体则以足够的量表达和分泌。天然存在的 G534E 变体表现出降低的蛋白水解活性。DeltaEGF-3 突变体与肝素的结合和激活作用减弱。因此,FSAP 活性的调控取决于其 EGF-3 结构域,活性变体的过表达会诱导细胞死亡。